PP
AXSM icon

Paloma Partners’s Axsome Therapeutics AXSM Stock Holding History

Paloma Partners’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-4,599
Closed -$311K – 1094
2021
Q2 		$311K Buy
+4,599
New +$276K 0.01% 1289
2020
Q3 		– Sell
-17,587
Closed -$1.45M – 2080
2020
Q2 		$1.45M Buy
+17,587
New +$1.35M 0.03% 759
2017
Q3 		– Sell
-48,900
Closed -$269K – 2091
2017
Q2 		$269K Buy
+48,900
New +$205K 0.01% 1849

Other funds holding AXSM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $186M AUM 51.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return